KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Non-Current Liabilities (2016 - 2021)

Abbott Laboratories' Total Non-Current Liabilities history spans 13 years, with the latest figure at -$20.9 billion for Q4 2021.

  • On a quarterly basis, Total Non-Current Liabilities rose 16.23% to -$20.9 billion in Q4 2021 year-over-year; TTM through Dec 2021 was -$20.9 billion, a 16.23% increase, with the full-year FY2021 number at -$20.9 billion, up 16.23% from a year prior.
  • Total Non-Current Liabilities hit -$20.9 billion in Q4 2021 for Abbott Laboratories, up from -$24.9 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ABT hit a ceiling of $48.2 billion in Q4 2017 and a floor of -$24.9 billion in Q4 2020.
  • Historically, Total Non-Current Liabilities has averaged $8.5 billion across 5 years, with a median of $1.3 billion in 2019.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 113.68% in 2017 and later plummeted 2024.46% in 2020.
  • Tracing ABT's Total Non-Current Liabilities over 5 years: stood at $48.2 billion in 2017, then decreased by 19.84% to $38.6 billion in 2018, then plummeted by 96.65% to $1.3 billion in 2019, then plummeted by 2024.46% to -$24.9 billion in 2020, then rose by 16.23% to -$20.9 billion in 2021.
  • Business Quant data shows Total Non-Current Liabilities for ABT at -$20.9 billion in Q4 2021, -$24.9 billion in Q4 2020, and $1.3 billion in Q4 2019.